Stock News

Universal Health Services, Inc. (UHS) Analysts See $2.59 EPS; Allena Pharmaceuticals (ALNA) Shorts Up By 53.3%

Universal Health Services, Inc. (NYSE:UHS) Logo

Allena Pharmaceuticals Inc (NASDAQ:ALNA) had an increase of 53.3% in short interest. ALNA’s SI was 118,500 shares in April as released by FINRA. Its up 53.3% from 77,300 shares previously. With 69,900 avg volume, 2 days are for Allena Pharmaceuticals Inc (NASDAQ:ALNA)’s short sellers to cover ALNA’s short positions. The SI to Allena Pharmaceuticals Inc’s float is 1.42%. The stock increased 1.94% or $0.26 during the last trading session, reaching $13.68. About 43,839 shares traded. Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) has 0.00% since April 17, 2017 and is . It has underperformed by 11.55% the S&P500.

Analysts expect Universal Health Services, Inc. (NYSE:UHS) to report $2.59 EPS on April, 25 after the close.They anticipate $0.49 EPS change or 23.33% from last quarter’s $2.1 EPS. UHS’s profit would be $243.77M giving it 11.64 P/E if the $2.59 EPS is correct. After having $2.00 EPS previously, Universal Health Services, Inc.’s analysts see 29.50% EPS growth. The stock increased 0.76% or $0.91 during the last trading session, reaching $120.55. About 460,158 shares traded. Universal Health Services, Inc. (NYSE:UHS) has declined 4.39% since April 17, 2017 and is downtrending. It has underperformed by 15.94% the S&P500.

Among 23 analysts covering Universal Health Services Inc. (NYSE:UHS), 15 have Buy rating, 0 Sell and 8 Hold. Therefore 65% are positive. Universal Health Services Inc. had 63 analyst reports since August 4, 2015 according to SRatingsIntel. Mizuho downgraded the stock to “Neutral” rating in Wednesday, November 9 report. As per Tuesday, December 19, the company rating was maintained by Credit Suisse. Mizuho maintained Universal Health Services, Inc. (NYSE:UHS) rating on Thursday, October 27. Mizuho has “Buy” rating and $142 target. The stock of Universal Health Services, Inc. (NYSE:UHS) has “Overweight” rating given on Thursday, October 1 by KeyBanc Capital Markets. The firm earned “Buy” rating on Tuesday, May 30 by RBC Capital Markets. Piper Jaffray maintained Universal Health Services, Inc. (NYSE:UHS) rating on Thursday, October 26. Piper Jaffray has “Buy” rating and $117.0 target. The stock of Universal Health Services, Inc. (NYSE:UHS) earned “Equal-Weight” rating by Morgan Stanley on Wednesday, June 7. The firm has “Buy” rating given on Sunday, August 27 by RBC Capital Markets. The company was maintained on Wednesday, August 9 by Piper Jaffray. The stock of Universal Health Services, Inc. (NYSE:UHS) has “Buy” rating given on Monday, March 5 by Credit Suisse.

Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, behavioral health facilities, and ambulatory centers. The company has market cap of $11.35 billion. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, pediatric services, pharmacy services, and/or behavioral health services. It has a 15.44 P/E ratio. As of February 28, 2017, it owned and/or operated 26 inpatient acute care hospitals, 4 free-standing emergency departments, 1 surgical hospital, and 319 inpatient and 33 outpatient behavioral health care facilities located in 37 states, Washington, D.C.; the United Kingdom; Puerto Rico; and the U.S.

Investors sentiment increased to 1.05 in Q4 2017. Its up 0.15, from 0.9 in 2017Q3. It improved, as 44 investors sold Universal Health Services, Inc. shares while 114 reduced holdings. 54 funds opened positions while 112 raised stakes. 80.04 million shares or 0.77% less from 80.67 million shares in 2017Q3 were reported. State Of New Jersey Common Pension Fund D has invested 0.03% in Universal Health Services, Inc. (NYSE:UHS). Stifel Financial Corp has invested 0.05% in Universal Health Services, Inc. (NYSE:UHS). Westpac Banking Corp stated it has 0.01% of its portfolio in Universal Health Services, Inc. (NYSE:UHS). Nokota Management Limited Partnership reported 289,082 shares. Cornerstone Cap Mgmt Hldg Ltd Liability Company owns 16,476 shares or 0.01% of their US portfolio. Royal Bank Of Canada has invested 0% in Universal Health Services, Inc. (NYSE:UHS). D E Shaw Company holds 0.07% or 456,351 shares. Benjamin F Edwards & invested in 0% or 100 shares. 140,891 were reported by Hsbc Public Limited Company. Mutual Of America Capital Management Limited Co accumulated 0.02% or 10,101 shares. Olstein Capital Mngmt L P owns 75,000 shares for 1.08% of their portfolio. Metropolitan Life Insurance Com Ny has invested 0.02% in Universal Health Services, Inc. (NYSE:UHS). Moreover, State Of Tennessee Treasury Department has 0.01% invested in Universal Health Services, Inc. (NYSE:UHS) for 22,671 shares. Moreover, Atlantic Limited Liability Company has 0.05% invested in Universal Health Services, Inc. (NYSE:UHS). Ellington Management Lc holds 0.08% or 4,100 shares in its portfolio.

Allena Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, engages in developing and commercializing oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States. The company has market cap of $283.12 million. The companyÂ’s lead product candidate includes ALLN-177, an oral enzyme therapeutic for the treatment of enteric hyperoxaluria, a metabolic disorder commonly associated with kidney stones in adults. It currently has negative earnings. It is also involved in developing ALLN-346 for patients with hyperuricemia and moderate to severe chronic kidney diseases.

Universal Health Services, Inc. (NYSE:UHS) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *